Where Are All the AI Drugs?
In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odds.
Cloning Came to Polo. Then Things Got Truly Uncivilized
A polo legend and a businessman joined forces to copy the player’s greatest horse. But with a single clone worth $800,000, some technologies are a breeding ground for betrayal.
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?